No Detail Found!

Role of Topiramate in Improving Quality of Life in Migraine Sufferers versus Gold Standard Propranolol.

Author(s)
M. Jamil Laghari Department of Pharmacology, Liaquat University of Medical & Health Sciences (LUMHS) Jamshoro, Sindh, Pakistan
Nasrin Qazi Department of Pharmacology, LUMHS, Jamshoro, Sindh, Pakistan
Shanawaz Jamali Department of Pharmacology, Hamdard University, Karachi, Sindh, Pakistan
Ghulam-Mustafa Department of Pharmacology, Mohammad Medical College, Mirpurkhas, Sindh, Pakistan
Abstract
Objective: To assess the role of Topiramate in reducing migraine related disability and improve- ment in quality of life in migraine sufferers comparing with conventionally used drug pro- pranolol. Background: Epilepsy and migraine have some biological features in common; therefore an- tiepileptic drugs are suppose to be effective in migraine prophylaxis beside active treatment, in reducing migraine headache attacks and therefore can improve sufferers’ quality of life. Methods: Seventy diagnosed patients of migraine were enrolled in the study and 64 completed the whole study period (12 weeks). They were divided in two groups: A (Topiramate) and B (Propanolol). MIDAS scores were observed at day-0 and day-90 and results were statistically analyzed. Results: Group received Topiramate showed better response and overall reduction was 62.51% (P-value
Publication Details
Page(s) 11-14
DOI DOI not available
Published Journal: Journal of Liaquat University of Medical and Health Sciences, Volume: 11, Issue: 1, Year: 2012

Request the full text from PASTIC

0

Citations

0

Downloads

42

Views